Cn. Robertson et al., DIFFERENTIAL IMMUNOREACTIVITY OF TRANSFORMING GROWTH-FACTOR-ALPHA IN BENIGN, DYSPLASTIC AND MALIGNANT PROSTATIC TISSUES, Surgical oncology, 3(4), 1994, pp. 237-242
Immunohistochemical examination of radical prostatectomy specimens fro
m 57 patients was performed to determine the differential expression o
f transforming growth factor alpha in the human prostate. In addition,
epidermal growth factor receptor (EGFr) immunoreactivity was assessed
in each case. Stromal versus epithelial staining was determined for e
ach histological subtype: benign prostatic hypertrophy (BPH), prostati
c intra-epithelial neoplasia (PIN), and prostatic cancer (CaP) by a si
ngle pathologist reviewer. TGFa staining was predominant in stroma whi
le EGFr was localized to the epithelial basal cell layer. Immunoreacti
vity of both TGFa (P = 0.002) and EGFr (P < 0.001) revealed a signific
ant reduction in CaP compared to BPH or PIN. Autocrine stimulation of
EGFr by TGFa or other unrecognized factors may be present in CaP. Conv
ersely, altered stromal influence of CaP via TGFa may be present. Thes
e observations could form the basis for future cancer therapeutic stra
tegies using antagonist factors.